[{"id":"2c723604-428f-416a-9baf-62d59cb55edd","acronym":"","url":"https://clinicaltrials.gov/study/NCT03821233","created_at":"2021-01-18T18:52:38.184Z","updated_at":"2025-02-25T17:36:12.613Z","phase":"Phase 1","brief_title":"A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers","source_id_and_acronym":"NCT03821233","lead_sponsor":"Zymeworks BC Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e zanidatamab zovodotin (ZW49)"],"overall_status":"Completed","enrollment":" Enrollment 112","initiation":"Initiation: 04/15/2019","start_date":" 04/15/2019","primary_txt":" Primary completion: 09/27/2024","primary_completion_date":" 09/27/2024","study_txt":" Completion: 10/08/2024","study_completion_date":" 10/08/2024","last_update_posted":"2025-01-29"}]